510(k) Report

PMA · Approved

Approved

Ventana Alk (D5F3) CDX Assay

P140025PMAApproved Jun 12, 2015210-day reviewClass III

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Ventana Medical Systems, Inc. · PKW Immunohistochemistry Assay, Antibody, Anaplastic Lymphoma Kinase

Approved on Jun 12, 2015 through premarket approval, which rests on the device’s own clinical evidence after a 210-day review.

Decided
Jun 12, 2015
Review
210 days
Class
Class III
Product code
PKW
Recalls
None

PMA approvals rest on their own clinical evidence and do not claim a predicate, so this family tree starts here.

P140025 has 23 supplements since 2015: changes to the approved device, its labelling or its manufacturing, each approved separately.

PMA supplements approved per year

2015: 12016: 22017: 42018: 22019: 12020: 22021: 22022: 42023: 22024: 12025: 2
2015high 4 (2017) · low 1 (2015)2025
View FIG. 1 as a table
YearSupplements approved
20151
20162
20174
20182
20191
20202
20212
20224
20232
20241
20252
FIG. 1 — Supplements to P140025, 2015–2025Source: FDA PMA database

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in PKW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

Does it have a predicate?

PMA decisions do not claim a predicate device.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All PKW devices

PKW Immunohistochemistry Assay, Antibody, Anaplastic Lymphoma Kinase: FDA decisions, review times, recalls and adverse event reports over 20 years. 2015, this device’s year, is highlighted.

FDA decisions per year · PKW

2in 2025

2015: 22016: 22017: 42018: 22019: 12020: 22021: 22022: 32023: 22024: 12025: 2
2007high 4 (2017) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PKW

Too few PKW 510(k)s in any year since 2007 to give a median.

Recalls per year · PKW

No recall names PKW since 2007.

Adverse event reports per year · PKW

1in 2024

2018: 22019: 12024: 1
2007high 2 (2018) · low 0 (2007)2025

MAUDE reports naming product code PKW, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20152—00
20162—00
20174—00
20182—02
20191—01
20202—00
20212—00
20223—00
20232—00
20241—01
20252—00
20260—0—
Cite this page

510(k) Report. “P140025: Ventana Alk (D5F3) CDX Assay.” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/P140025

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026